Form 4: NeuroOne Medical Technologies Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Mark Christianson, Business Development Director at NeuroOne Medical Technologies, disposed of 1,812 shares of common stock on February 18, 2025, to cover tax obligations.
Summary
- On February 18, 2025, Mark Christianson, the Business Development Director of NeuroOne Medical Technologies Corp, sold 1,812 shares of common stock.
- The transaction was executed at a price of $1.16 per share.
- This sale was conducted to cover tax obligations related to previously acquired shares.
- Following the transaction, Christianson directly owns 291,744 shares of NeuroOne Medical Technologies Corp.
Sentiment
Score: 5
Explanation: This is a neutral event. An executive selling shares to cover tax obligations is a routine transaction and doesn't necessarily indicate a positive or negative outlook for the company.
Industry Context
Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders. This transaction is a common occurrence where executives sell shares to cover tax obligations.
Stakeholder Impact
- The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 02/18/2025 | Date of transaction: Mark Christianson disposed of 1,812 shares of common stock. |
| 02/20/2025 | Date of signature: The Form 4 was signed on this date. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.